GlassScriptPhysician profile
David H Hsi
NPI 1588616312
$4,845.85
in general payments reported to CMS, 2019-2025
17 companies · $477 in 2025
The $477 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,681 · 2020: $22.93 · 2021: $154 · 2023: $344 · 2024: $166 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $987.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $987.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,403.68 | 2019 | |
| Abbott Laboratories | $548.47 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| E.R. Squibb & Sons, L.L.C. | $280.53 | 2025 | Camzyos, Cobenfy |
| Bridgebio Pharma, INC. | $149.22 | 2025 | Attruby |
| Silk Road Medical, INC. | $119.50 | 2019 | |
| Esperion Therapeutics, INC. | $110.93 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $84.97 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $32.05 | 2025 | |
| Preventice Services, LLC | $22.93 | 2020 | |
| Irhythm Technologies, INC. | $22.82 | 2024 | Zio Xt Patch, Zio Monitor |
| Siemens Medical Solutions USA, INC. | $21.92 | 2023 | Naeotom Alpha |
| Merck Sharp & Dohme LLC | $18.74 | 2024 | Verquvo |
| Alnylam Pharmaceuticals INC. | $15.53 | 2025 | Onpattro |
| Pfizer INC. | $14.56 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hsi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.